Form 4 for SRTA Strata Critical Medical, Inc.
Accepted 2026-09-25 16:12:32 ET · period of report 2026-09-24 · accession 0001628280-26-063577 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-09-25 16:12 | 2026-09-24 | SRTA | Tomkiel Melissa M. | GC, Co-CEO, Dir | A - Grant | $0.00 | +177.9K | 2.24M | +9% | $0 | |
| 2026-09-25 16:12 | 2026-09-24 | SRTA | Tomkiel Melissa M. | GC, Co-CEO, Dir | F - Tax | $5.27 | -90.8K | 2.15M | -4% | -$478.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A common stock, $0.0001 par value per share | 2026-09-24 | A | A | 177,858 | $0.00 | 2,244,475 | D | — | — | (F1) Represents shares that were acquired upon the certification of the Compensation Committee of the Issuer's Board of Directors of the satisfaction of performance criteria underlying an award of performance-based restricted stock units ("PSUs") granted to the Reporting Person on August 29, 2026 |
| 2 | Common | Class A common stock, $0.0001 par value per share | 2026-09-24 | F | D | 90,797 | $5.27 | 2,153,678 | D | — | — | (F2) Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of PSUs |